PET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by Surgery

Completed · Phase 2/Phase 3

Conditions studied: Esophageal Cancer, Lung Cancer

In brief

RATIONALE: Imaging procedures, such as fludeoxyglucose F 18 positron emission tomography (PET) scans, may improve the ability to detect lung and esophageal cancer or their recurrence. PURPOSE: Phase II/III trial to study the effectiveness of fludeoxyglucose F 18 PET scans in measuring response to induction chemotherapy in patients with esophageal and lung cancer that may be removed by surgery.

Key facts

Study ID

NCT00002930

Run by

Memorial Sloan Kettering Cancer Center

People needed

75

Starts

1996-12-01

Last updated by the study team

2013-01-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.